A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea.
Clinical trial NCT05296629 · COMPLETED
Trial details
- NCT number
- NCT05296629
- Sponsor
- Journey Medical Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-14
- Primary completion
- 2023-06-30
- Enrollment
- 323
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.